CVE-2022-48999

ipv4: Handle attempt to delete multipath route when fib_info contains an nh reference

Description

In the Linux kernel, the following vulnerability has been resolved: ipv4: Handle attempt to delete multipath route when fib_info contains an nh reference Gwangun Jung reported a slab-out-of-bounds access in fib_nh_match: fib_nh_match+0xf98/0x1130 linux-6.0-rc7/net/ipv4/fib_semantics.c:961 fib_table_delete+0x5f3/0xa40 linux-6.0-rc7/net/ipv4/fib_trie.c:1753 inet_rtm_delroute+0x2b3/0x380 linux-6.0-rc7/net/ipv4/fib_frontend.c:874 Separate nexthop objects are mutually exclusive with the legacy multipath spec. Fix fib_nh_match to return if the config for the to be deleted route contains a multipath spec while the fib_info is using a nexthop object.

Category

7.1
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.11%
Affected: Linux Linux
Affected: Linux Linux
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-48999?
CVE-2022-48999 has been scored as a high severity vulnerability.
How to fix CVE-2022-48999?
To fix CVE-2022-48999, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-48999 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-48999 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-48999?
CVE-2022-48999 affects Linux Linux, Linux Linux.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.